203 related articles for article (PubMed ID: 31897169)
1. CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinoma.
Yu H; Yao J; Du M; Ye J; He X; Yin L
Oncol Lett; 2020 Jan; 19(1):542-548. PubMed ID: 31897169
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma.
Liu J; Min L; Zhu S; Guo Q; Li H; Zhang Z; Zhao Y; Xu C; Zhang S
J Cancer; 2019; 10(8):1915-1922. PubMed ID: 31205550
[No Abstract] [Full Text] [Related]
3. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
[TBL] [Abstract][Full Text] [Related]
4. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
5. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
Zhu ZQ; Hu HF; Zheng XY; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
[No Abstract] [Full Text] [Related]
6. ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway.
Yin H; Wang L; Li F; Wang D; Zhang Z; Yu B; Liu Y
Transl Cancer Res; 2020 May; 9(5):3282-3292. PubMed ID: 35117695
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
[TBL] [Abstract][Full Text] [Related]
9. KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling.
Hao WW; Xu F
World J Gastrointest Oncol; 2022 Jul; 14(7):1239-1251. PubMed ID: 36051093
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
[TBL] [Abstract][Full Text] [Related]
11. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
Zhang J; Liu S; Zhang D; Ma Z; Sun L
J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
[TBL] [Abstract][Full Text] [Related]
12. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
[TBL] [Abstract][Full Text] [Related]
13. TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.
Zeng YZ; Zhang YQ; Chen JY; Zhang LY; Gao WL; Lin XQ; Huang SM; Zhang F; Wei XL
Front Oncol; 2021; 11():627713. PubMed ID: 33854967
[TBL] [Abstract][Full Text] [Related]
14. Protein Arginine Methyltransferase 5 Promotes Esophageal Squamous Cell Carcinoma Proliferation and Metastasis via LKB1/AMPK/mTOR Signaling Pathway.
Chen YR; Li HN; Zhang LJ; Zhang C; He JG
Front Bioeng Biotechnol; 2021; 9():645375. PubMed ID: 34124017
[No Abstract] [Full Text] [Related]
15. Long non‑coding RNA DLX6‑AS1 is associated with malignant progression and promotes proliferation and invasion in esophageal squamous cell carcinoma.
Wang M; Li Y; Yang Y; Liu X; Zang M; Li Y; Yang K; Yang W; Zhang S
Mol Med Rep; 2019 Mar; 19(3):1942-1950. PubMed ID: 30592268
[TBL] [Abstract][Full Text] [Related]
16. Bufalin suppresses esophageal squamous cell carcinoma progression by activating the PIAS3/STAT3 signaling pathway.
Ju Q; Shi Q; Liu C; Fu G; Shi H
J Thorac Dis; 2023 Apr; 15(4):2141-2160. PubMed ID: 37197494
[TBL] [Abstract][Full Text] [Related]
17. ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway.
Huang W; Zhu J; Shi H; Wu Q; Zhang C
Onco Targets Ther; 2021; 14():3583-3596. PubMed ID: 34113124
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
[TBL] [Abstract][Full Text] [Related]
19. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
Zhao Y; Wang Y; Xing G
Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
[TBL] [Abstract][Full Text] [Related]
20. miR-196a regulates the proliferation, invasion and migration of esophageal squamous carcinoma cells by targeting ANXA1.
Hu C; Peng J; Lv L; Wang X; Zhou Y; Huo J; Liu D
Oncol Lett; 2019 Jun; 17(6):5201-5209. PubMed ID: 31186736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
